Back to search

Sweden· SE-20120705000069

Confidex 1000 IE Pulver och vätska till injektionsvätska, lösning

A medicinal product containing human coagulation factor ix + protein c + human coagulation factor vii + protein s + human coagulation factor ii + human coagulation factor x, registered in Sweden by CSL Behring GmbH.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedConfidex 1000 IE Pulver och vätska ti…ATC—REGISTER NO.SE-20120705000069PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Human Coagulation Factor Ix + Protein C + Human Coagulation Factor Vii + Protein S + Human Coagulation Factor Ii + Human Coagulation Factor X
Manufacturer
CSL Behring GmbH
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20120705000069

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Human coagulation factor ix + protein c + human coagulation factor vii + protein s + human coagulation factor ii + human coagulation factor x in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All human coagulation factor ix + protein c + human coagulation factor vii + protein s + human coagulation factor ii + human coagulation factor x products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Beriplex P/N, Cofact
  • Belgium · Cofact, Confidex
  • Bulgaria · Octaplex, Бериплекс P/N
  • Cyprus · Beriplex P/N, Octaplex
  • Czechia · Beriplex, Ocplex
  • Germany · Beriplex P/N, Cofact
  • Denmark · Confidex, Octaplex
  • Estonia · Octaplex
  • Spain · Beriplex, Cofact
  • Finland · Cofact, Confidex
  • France · Cofact, Confidex
  • United Kingdom (Northern Ireland) · Beriplex P/N, Octaplex
  • Greece · Beriplex P/N
  • Croatia · Beriplex P/N, Octaplex
  • Hungary · Beriplex P/N, Octaplex
  • Ireland · Beriplex P/N, Octaplex Coagulation Factor Ix
  • Iceland · Cofact, Octaplex
  • Italy · Cofact, Confidex
  • Lithuania · Octaplex
  • Luxembourg · Cofact, Confidex
  • Latvia · Octaplex
  • Malta · Beriplex P/N, Octaplex
  • Netherlands · Beriplex P/N, Cofact
  • Norway · Confidex, Octaplex
  • Poland · Beriplex P/N, Octaplex
  • Portugal · Beriplex, Octaplex
  • Romania · Beriplex P/N, Pronativ
  • Slovenia · Beriplex P/N, Octaplex
  • Slovakia · Beriplex, Octaplex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/98c9b56b-dd12-4555-a7dd-de9536b05357
GET /v1/drugs/98c9b56b-dd12-4555-a7dd-de9536b05357?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20120705000069",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120705000069",
  "product_doc_link": "https://docetp.mpa.se/LMF/Confidex%20powder%20and%20solvent%20for%20solution%20SmPC_09001bee807a3a00.pdf"
}

See everything about human coagulation factor ix + protein c + human coagulation factor vii + protein s + human coagulation factor ii + human coagulation factor x.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.